Pulmonary insulin delivery - State of the art 2007

Diabetes Technology and Therapeutics

Volumn 9, Issue SUPPL. 1, 2007, Pages

  Skyler, Jay S ^a,b  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b DIABETES RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN;

CONFERENCE PAPER; DIABETES MELLITUS; DRUG DELIVERY SYSTEM; GLYCEMIC CONTROL; INSULIN TREATMENT; LUNG FUNCTION; PRIORITY JOURNAL;

ADMINISTRATION, INHALATION; AEROSOLS; DIABETES MELLITUS; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; LUNG;

EID: 34250749177     PISSN: 15209156     EISSN: None     Source Type: Journal    
DOI: 10.1089/dia.2007.0241     Document Type: Conference Paper

References (39)

1. Heubner W, De Jongh SE, Laquer E: Über Inhalation von Insulin. Klin Wochenschr 1924;3:2342-2343.
2. Gänsslein M: Über Inhalation von Insulin. Klin Wochenschr 1925;4:71.
3. Heubner W: Über Inhalation, Insbesondere von Insulin. MÅnch Med Wochenschr 1925;67:244-245.
4. Inhalation of insulin. JAMA 1925;84:634.
5. Silten E: Bemerkungen zur Technik der Insulinin-halation. Med Klin 1925;35:1309.
6. Palm A: Versuche Über Inhalation von Insulin. Z Ges Exp Med 1927;55:432-444.
7. Wilkoewitz K, Schiebe H: Die Wirkung der Insulin-inhalation bei Atmungsvertiefung Durch Kohlensäure. Z Ges Exp Med 1931;78:757-7630.
8. Oe, Otohiko: Beeinflussung des Blutzuckergehaltes durch die Inhalation einiger inkretorischer Organpräparate. I. Insulin. Acta Dermatol 1938;31(5-6):75-86.
9. Kourilsky R, Biancani H, Delaville GM: L'action thärapeutique des microbrouillards. Effets de l'insuline introduite par cette voie chez les diabétiques. Bull Mem Soc Med Hop Paris 1941;200-202.
10. Lenti G, Ancona F: Sulle modificazioni della glicemia indotte dall'aerosol die insulina nei normali e nei diabetici. Minerva Pediatr 1949;10:354-355.
11. Knick B, Wehr J: Insulinwirkung dei Organnaher Anwendung Durch Aerosol. Klin Wochenschr 1953;31: 310-311.
12. Knick B, Wehr J, Wasielewski EV: Insulin-Aerosole. Z Aerosol-Forsch 1953;2:736-743.
13. Stöcker W: Zur Geschichte des Diabetes Mellitus. Therapiewoche 1966;16:1077-1082.
14. Wigley FW, Londono JH, Wood SH, Shipp JC, Waldman RH: Insulin across respiratory mucosae by aerosol delivery. Diabetes 1971;20:552-556.
15. Köhler D, Schluter KJ, Kerp L, Matthys H: Nicht Radioaktives Verfahren zur Mhessung der Lungenpermeabilität: Inhalation von Insulin. Atermw Lungenkrkh 1987;13:230-232.
16. Elliott RB, Edgar BW, Pilcher CC, Quested C, McMaster J: Parenteral absorption of insulin from the lung in diabetic children. Aust Paediatr J 1987;23: 293-297.
17. Laube BL, Georgopoulos A, Adams GK: Aerosolized insulin delivered through the lungs is effective in normalizing plasma glucose levels in non-insulin dependent diabetic subjects (NIDD). J Biopharm Sci 1992;3: 163-169.
18. Laube BL, Georgopoulos A, Adams GK: Preliminary study of the efficacy of insulin aerosol delivered by oral inhalation in diabetic patients. JAMA 1993;269: 2106-2109.
19. Jendle J, Karlberg BE, Persliden J, Franzen L, Arborelius M: Delivery and retention of an insulin aerosol produced by a new jet nebulizer. J Aerosol Med 1995;8:243-254.
20. Edwards DA, Hanes J, Caponetti G, Hrkach J, Ben-Jebria A, Eskew ML, Mintzes J, Deaver D, Lotan N, Langer R: Large porous particles for pulmonary drug delivery. Science 1997;276:1868-1871.
21. Heinemann L, Traut T, Heise T: Time-action profile of inhaled insulin. Diabet Med 1997;14:63-72.
22. Laube BL, Benedict GW, Dobs AS: The lung as an alternative route of delivery for insulin in controlling postprandial glucose levels in subjects with diabetes. Chest 1998;114:1734-1739.
23. Chakraborti RN: Bronchopulmonary absorption of aerosolised insulin. J Indian Med Assoc 1999;97:493-495.
24. Kawashima Y, Yamamoto H, Takeuchi H, Fujioka S, Hino T: Pulmonary delivery of insulin with nebulized DL-lactide/glycolide copolymer (PLGA) nanospheres to prolong hypoglycemic effect. J Control Release 1999;62:279-287.
25. Heinemann L, Klappoth W, Rave K, Hompesch B, Linkeschowa R, Heise T: Related intra-individual variability of the metabolic effect of inhaled insulin together with an absorption enhancer. Diabetes Care 2000;23:1343-1347.
26. Wollmer P, Pieber TR, Gall M-A, Brunton S: Delivering needle-free insulin using AERx® IDMS (insulin diabetes management system) technology. Diabetes Technol Ther 2007;9(Suppl 1):S-57-S-64.
27. Richardson PC, Boss AH: Technosphere® Insulin technology. Diabetes Technol Ther 2007;9(Suppl 1):S-65-S-72.
28. Muchmore DB, Silverman B, de la Peña A, Tobian J: The AIR® inhaled insulin system: system components and pharmacokinetic/glucodynamic data. Diabetes Technol Ther 2007;9(Suppl 1):S-41-S-47.
29. Ellis SL, Gemperline KA, Garg S: Review of phase 2 studies utilizing the AIR® particle technology in the delivery of human insulin inhalation powder versus subcutaneous regular or lispro insulin in subjects with type 1 or type 2 diabetes. Diabetes Technol Ther 2007;9(Suppl 1):S-48-S-56.
30. Harper NJ, Gray S, de Groot J, Parker JM, Sadrzadeh N, Schuler C, Schumacher JD, Seshadri S, Smith AE, Steeno GS, Stevenson CL, Taniäre R, Wang M, Bennett DB: The design and performance of the Exubera® pulmonary insulin delivery system. Diabetes Technol Ther 2007;9(Suppl 1):S-16-S-27.
31. Cefalu WT, Wang ZQ: Clinical research observations with use of Exubera® in patients with type 1 and type 2 diabetes. Diabetes Technol Ther 2007;9(Suppl 1): S-28-S-40.
32. Heinemann L, Heise T: Current status of the development of inhaled insulin. Br J Diabetes Vasc Dis 2004;4:295-301.
33. Brain JD: Inhalation, deposition, and fate of insulin and other therapeutic proteins. Diabetes Technol Ther 2007;9(Suppl 1):S-4-S-15.
34. Hsia CCW, Raskin P: Lung function changes related to diabetes mellitus. Diabetes Technol Ther 2007; 9(Suppl 1):S-73-S-82.
35. Hegewald M, Crapo RO, Jensen RL: Pulmonary function changes related to acute and chronic administration of inhaled insulin. Diabetes Technol Ther 2007; 9(Suppl 1):S-93-S-101.
36. Mudaliar S, Henry RR: Inhaled insulin in patients with asthma and chronic obstructive pulmonary disease. Diabetes Technol Ther 2007;9(Suppl 1):S-83-S-92.
37. Fineberg SE, Kawabata TT, Krasner AS, Fineberg NS: Insulin antibodies with pulmonary delivery of insulin. Diabetes Technol Ther 2007;9(Suppl 1): S-102-S-110.
38. Hirsch IB: Arguments against the use of inhaled insulin. Diabetes Technol Thr 2007;9(Suppl 1):S-111-S-114.
39. Food and Drug Administration: Briefing information, September 8, 2005. Presented at the Endocrinology and Metabolic Drugs Advisory Committee Meeting, 2005. Online at http://www.fda.gov/ohrms/dockets/ ac/cder05. html#EndocrinologicMetabolic (accessed January 12, 2007).